Table 2.

Prevalence by continent, source, and outcomes of SBP in cirrhosis.

	No. of papers	Sample (cirrhosis)	Events (SBP)	Pooled prevalence (95% CI)
Overall	99	5,861,142	143,908	–
Overall prevalence	72	5,717,234	138,302	17.12% (13.63–21.30%)
Continent
Africa	2	134	60	44.54% (18.15−0.7442%)
North America	13	5,658,362	131,851	10.81% (5.32–20.73%)
Asia Pacific	16	30,699	2,085	14.08% (7.70–24.36%)
South Asia	10	3,297	625	17.73% (12.34–24.79%)
Middle East	6	1,444	263	19.42% (9.51–35.59%)
Europe	19	22,351	3,229	18.4% (13.12–25.18%)
Latin America	3	947	194	21.17% (16.84–26.26%)
Source of infection
Healthcare associated	4	1,301	132	11.11% (5.84–20.11%)
Community acquired	10	4,611	305	6.05% (4.32–8.40%)
Outcomes
Mortality	21	4,753	1,455	30.61% (23.30–39.06%)
In hospital mortality	14	17,037	3,983	23.38% (15.18–34.22%)
30-day mortality	12	3,719	953	25.64% (22.46–29.11%)
90-day mortality	8	2,515	946	37.64% (31.62–44.08%)
Recurrence	3	394	62	15.74% (12.46–19.67%)
Acute kidney injury	5	116,207	57,383	49.38% (30.76–68.18%)